ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Malignancy"

  • 2022 American Transplant Congress

    Kidney Transplantation in Patients Postradical Prostatectomy

    S. Karhadkar, K. Wirshup, J. Kolansky, A. Gregor, J. Dawes, A. DiCarlo

    Temple University Hospital, Philadelphia, PA

    *Purpose: The population of the United States is aging. By the year 2050 those over 65 years of age are projected to make up 20.2%…
  • 2022 American Transplant Congress

    Donor-Derived Duodenal Adenocarcinoma of a Bladder-Drained Pancreas Allograft

    D. Isaacson1, J. Steggerda1, Y. Xue1, G. B. Auffenberg2, N. N. Katariya3

    1Northwestern University, Chicago, IL, 2Urology of St. Louis, St. Louis, MO, 3Mayo Clinic, Phoenix, AZ

    *Purpose: Donor-derived malignancies are rare but frequently present with aggressive pathology and high mortality rates [PMID 32627325]. The urologic literature demonstrates an increased risk of…
  • 2022 American Transplant Congress

    Characterizing the Landscape of Cancer Risk Following HLA-Incompatible Living Donor Kidney Transplantation

    J. D. Motter1, K. Jackson1, K. Yu2, R. M. Pfeiffer2, A. Massie1, J. Garonzik-Wang3, D. Segev1, E. A. Engels2

    1Johns Hopkins University, Baltimore, MD, 2National Cancer Institute, Bethesda, MD, 3University of Wisconsin-Madison, Madison, WI

    *Purpose: Incompatible living donor kidney transplant recipients (ILDKTr) require desensitization to facilitate transplantation across donor-specific antibody (DSA); however, this substantial upfront immunosuppression may result in…
  • 2022 American Transplant Congress

    Immunotherapy Before Solid Organ Transplantation: An International Transplant Community-Focused Survey

    T. Ivanics1, M. P. Claasen1, D. Al-Adra2, G. Sapisochin3

    1University of Toronto - University Health Network, Toronto, ON, Canada, 2Division of Transplantation, Department of Surgery, University of Wisconsin School of Medicine and Public Health, Madison, WI, 3Multi-organ transplant program, University Health Network, Toronto, ON, Canada

    *Purpose: The use of immunotherapy for cancer has increased and is expected to continue to grow. The outcomes after solid organ transplantation (SOT) in patients…
  • 2022 American Transplant Congress

    Association of Native Kidney Disease with De Novo Cancer Development After Kidney Transplant

    Y. Caliskan1, D. Axelrod2, R. Li1, W. Cheungpasitporn3, M. Schnitzler1, M. McAdams DeMarco4, J. Ahn4, T. Alhamad5, H. Randall1, S. Bae4, D. Segev4, K. L. Lentine1

    1Saint Louis University, Saint Louis, MO, 2University of Iowa, Iowa City, IA, 3Mayo Clinic, Rochester, MN, 4John Hopkins University, Baltimore, MD, 5Washington University in Saint Louis, Saint Louis, MO

    *Purpose: Primary glomerulonephritis (GN) and congenital anomalies of the kidney and urinary tract (CAKUT) have been shown to be associated with cancer development in the…
  • 2022 American Transplant Congress

    Treg Crosstalk with Both Tumor and Lymphatic Cells Promotes Metastasis Through Lta1b2-ltbr Signaling

    W. Piao1, R. S. Oakes2, C. M. Jewell2, J. Bromberg1

    1Surgery, University of Maryland, Baltimore, MD, 2University of Maryland, College Park, MD

    *Purpose: Lymphotoxin (LT) α1β2 high expressing Tregs are essential for immune tolerance although inhibiting antitumor immunity. Lymphatic endothelial cells (LEC) express the LT beta-receptor (LTβR),…
  • 2021 American Transplant Congress

    Outcomes of Surgical Resection versus Liver Transplantation in Hilar Cholangiocarcinoma

    M. K. White1, F. Aucejo2, A. Moro2, K. Sasaki2, K. Stephans3, B. Estfan4, C. Quintini2, B. Eghtesad2, K. Hashimoto2, F. Masato2, C. Miller2, K. Menon5

    1Cleveland Clinic, Cleveland, OH, 2General Surgery, Cleveland Clinic, Cleveland, OH, 3Radiation Oncology, Cleveland Clinic, Cleveland, OH, 4Oncology, Cleveland Clinic, Cleveland, OH, 5Gastroenterology & Hepatology, Cleveland Clinic, Cleveland, OH

    *Purpose: To compare the outcomes of patients with hilar cholangiocarcinoma (hCCA) who underwent either surgical resection or liver transplantion (LT).*Methods: All hCCA patients who underwent…
  • 2021 American Transplant Congress

    Incidentally Detected Malignancies in Lung Explants: Single Center Case Series

    D. Razia, A. Arjuna, L. Schaheen, J. Huang, M. Smith, R. Bremner, R. Walia

    Thoracic Surgery and Lung Transplantation, Norton Thoracic Institute, St. Joseph's Hospital and Medical Center, Phoenix, AZ

    *Purpose: Thoracic malignancies are difficult to prospectively diagnose in patients with end-stage lung disease due to complex radiologic features. We present a series of lung…
  • 2021 American Transplant Congress

    Cancer-Specific Mortality in Solid Organ Transplant Recipients with a Prior Cancer Diagnosis

    E. Engels1, G. Haber1, A. Hart2, C. Lynch3, J. Li4, K. Pawlish4, B. Qiao5, K. Yu1, R. Pfeiffer1

    1Natl Cancer Inst, Bethesda, MD, 2Univ of Minnesota, Minneapolis, MN, 3Univ of Iowa, Iowa City, IA, 4New Jersey Dept of Health, Trenton, NJ, 5New York State Dept of Health, Albany, NY

    *Purpose: A history of cancer is increasingly common among solid organ transplant candidates, and transplant-associated immunosuppression may increase recurrence risk. We assessed whether transplantation was…
  • 2021 American Transplant Congress

    Review of Outcomes After Diagnosis of Malignancy in Kidney Transplant Patients: Unos Database

    H. Patel1, N. Agrawal1, R. Gupta1, P. Geetha2, A. Abdul Razzack3, F. Cardarelli1

    1Transplant Nephrology, Beth Israel Deaconess Medical Center, Boston, MA, 2Nephrology, Beth Israel Deaconess Medical Center, Boston, MA, 3Medicine, Dr. NTR University of Health Sciences, Vijaywada, India

    *Purpose: Malignancy is the third major cause of death among transplant recipients. Among the transplant recipients, Patient and kidney transplant outcomes after the diagnosis of…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • …
  • 20
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences